Nystatin (Fungicidin): Polyene Antifungal Agent for Candida and Mycoplasma Research

Executive Summary: Nystatin (Fungicidin) is a polyene antifungal antibiotic that binds ergosterol in fungal cell membranes, causing pore formation and rapid cell death (APExBIO). It exhibits potent activity against Candida albicans and non-albicans Candida species, with MIC90 values around 4 mg/L for C. albicans and 0.39–3.12 μg/mL for others (Pha-793887 article). Nystatin is insoluble in water and ethanol but dissolves in DMSO at ≥30.45 mg/mL, requiring -20°C storage for long-term stability. In animal models, liposomal Nystatin formulations protect neutropenic mice from Aspergillus infections at doses as low as 2 mg/kg/day. Importantly, Nystatin does not inhibit all endocytic pathways, as shown in Drosophila S2 cells infected with Spiroplasma eriocheiris (Wei et al. 2019).

Biological Rationale

Nystatin (Fungicidin) is a natural polyene macrolide produced by Streptomyces noursei. Its primary target is the fungal cell membrane, where it binds ergosterol, a sterol unique to fungi (related article). Ergosterol binding leads to membrane destabilization, a mechanism absent in mammalian cells, enabling selective toxicity. The drug's broad-spectrum antifungal activity is well-documented, particularly against pathogenic Candida species and mycoplasma. Nystatin is widely used in laboratory research to investigate antifungal mechanisms, susceptibility, and resistance. Its unique action profile positions it as a reference compound for comparative studies and therapeutic modeling (Amyloid-peptide-10-20-human article—this article extends the referenced guide by providing detailed benchmarks, mechanistic context, and caveats).

Mechanism of Action of Nystatin (Fungicidin)

Nystatin exerts antifungal effects by binding directly to ergosterol within the fungal plasma membrane (APExBIO product page). This interaction forms transmembrane pores, increasing membrane permeability and leading to leakage of vital cellular components. The result is osmotic imbalance and rapid fungal cell death. Nystatin does not interact with cholesterol in mammalian cell membranes, accounting for its selective antifungal toxicity (Amyloid-protein-1-15 article—this article clarifies the ergosterol-specificity of Nystatin compared to earlier summaries).

Resistance to Nystatin is rare but can occur via reduced ergosterol content or altered membrane composition. In laboratory models, Nystatin’s membrane-disruptive action is observable as increased dye uptake, loss of membrane potential, and cell lysis. The drug is ineffective against fungi lacking ergosterol (such as some zygomycetes or highly resistant strains) and does not target bacteria or viruses.

Evidence & Benchmarks

• Nystatin inhibits Candida albicans with MIC90 values near 4 mg/L in standardized growth media (APExBIO).
• MIC ranges for non-albicans Candida (e.g., C. glabrata, C. parapsilosis, C. tropicalis, C. krusei) span 0.39–3.12 μg/mL under CLSI conditions (Pha-793887).
• Liposomal Nystatin at 2 mg/kg/day protects neutropenic mice from experimental Aspergillus infection (Amyloid-peptide-10-20-human).
• Nystatin reduces adhesion of Candida species to human buccal epithelial cells, with greater effect on non-albicans species (Pha-793887).
• In Drosophila S2 cells, Nystatin does not block Spiroplasma eriocheiris entry, confirming specificity for ergosterol-rich membranes (Wei et al., 2019, DOI).
• Nystatin is insoluble in water and ethanol but dissolves in DMSO at ≥30.45 mg/mL; optimal storage is at -20°C (APExBIO).

Applications, Limits & Misconceptions

Nystatin (Fungicidin) is routinely used in antifungal susceptibility testing, cell culture decontamination, and models of fungal infection. Its benchmarked MICs enable standardized comparisons across studies (VX-661 article—this article updates the referenced guide with recent in vivo and cell line data). The compound is also employed in mechanistic studies of membrane disruption and fungal adhesion dynamics. Liposomal and other advanced formulations have expanded its application in animal models, particularly for Aspergillus challenges in immunocompromised hosts. Nystatin’s specificity for ergosterol makes it unsuitable for bacteria, viruses, or ergosterol-deficient fungi.

Common Pitfalls or Misconceptions

• Nystatin does not inhibit caveola-mediated endocytosis: In Drosophila S2 cells, Nystatin failed to block Spiroplasma eriocheiris entry, underscoring its membrane specificity (Wei et al., 2019).
• Inactive against bacteria and viruses: Nystatin targets ergosterol, which is absent in prokaryotes and viruses.
• Solubility limitations: Nystatin is insoluble in water and ethanol; DMSO or similar solvents are required for stock preparation (APExBIO).
• Long-term solution storage is not recommended: Nystatin solutions degrade rapidly; use freshly prepared stocks for reproducible results.
• Misattribution of cellular effects: Observed cytotoxicity in non-fungal systems may reflect solvent effects rather than Nystatin action.

Workflow Integration & Parameters

Nystatin (Fungicidin), supplied by APExBIO (SKU: B1993), is available as a crystalline solid with a molecular weight of 926.09 and formula C₄₇H₇₅NO₁₇. For laboratory use, dissolve in DMSO at concentrations ≥30.45 mg/mL. Stock solutions should be prepared by gentle warming and ultrasonic agitation. Store at -20°C for several months; avoid repeated freeze-thaw cycles. Working solutions should be prepared fresh and used promptly.

For antifungal susceptibility testing, use standardized microdilution or agar-based protocols. Benchmark against reported MIC values for Candida spp. For cell culture decontamination, typical working concentrations range from 50–100 units/mL, but titration is advised to minimize cytotoxicity. For animal models, follow published dosing regimens (e.g., 2 mg/kg/day for liposomal Nystatin in neutropenic mice). Always confirm solubility and compatibility with assay conditions.

For further protocol optimization and troubleshooting in antifungal research, see the APExBIO product page for Nystatin (Fungicidin) and additional guides, such as the VX-661 workflow article (this article provides updated storage and solubility recommendations).

Conclusion & Outlook

Nystatin (Fungicidin) remains a reference polyene antifungal for laboratory research, benchmarking, and mechanistic studies. Its ergosterol-targeted action, broad antifungal spectrum, and robust performance in model systems underpin its continued utility. Ongoing research into new formulations and resistance mechanisms will further define its application boundaries. For detailed product specifications and ordering, refer to the Nystatin (Fungicidin) B1993 kit at APExBIO. Researchers are encouraged to leverage recent evidence for reproducible, high-confidence antifungal workflows.